Opinion: Long COVID is solvable, but we need more clinical trials

Some people may remain ill after COVID infection because the virus still lurks in their bodies. The looming question now is: Who will pay for drug development and trials?

 Some people may remain ill after COVID infection because the virus still lurks in their bodies. The looming question now is: Who will pay for drug development and trials?  Health & Wellness

Leave a Reply

Your email address will not be published. Required fields are marked *